军事知识服务平台
无创机械通气对伴高碳酸血症的稳定期慢性阻塞性肺疾病患者的治疗作用
Clinical observation of home noninvasive positive pressure ventilation in hypercapnic patient with stable severe chronic obstructive pulmonary disease
摘要 目的 评估家庭无创正压机械通气(HNIPPV)在治疗伴高碳酸血症的稳定期重度慢性阻塞性肺疾病(COPD)患者中的效果及安全性.方法 回顾性分析2009年1月至2010年12月在哈尔滨医科大学附属第二医院呼吸内科经住院治疗处于稳定期而出院的106例重度COPD患者中动脉血二氧化碳分压( PaCO2)≥55 mm Hg的44例患者的临床资料(男30例,女14例,年龄60~80岁,平均68.5岁).其中20例(HNIPPV组)采用多索茶碱片口服+噻托溴铵吸入+HNIPPV治疗,24例(对照组)采用多索茶碱片口服+噻托溴铵吸入+持续低流量吸氧治疗,总观察时间为6个月.对治疗前、治疗6个月后两组患者的肺功能、6 min步行距离(6MWD)、动脉血氧分压(PaO2)、PaCO2、呼吸困难分级评分、心理情绪评分及平均肺动脉压(mPAP)进行对比分析.结果 两组基线资料比较差异无统计学意义.治疗前两组第1秒用力呼气容积( FEV1)、用力肺活量(FVC)、深吸气量(IC)、6MWD、PaO2、PaCO2、呼吸困难分级评分、住院率、焦虑评分、抑郁评分、mPAP差异均无统计学意义(均P>0.05).治疗6个月后HNIPPV组IC、6MWD、PaO2 、PaCO2、呼吸困难分级评分、焦虑评分、抑郁评分、mPAP分别为(1.80±0.14)L、(266±24)m、(62.6±4.6) mm Hg(1 mm Hg =0.133 kPa)、(46.8±2.2) mmHg、(2.2±0.5)分、(6.5±2.4)分、(6.0±1.6)分、(33.8±2.4) mmHg,与对照组[(1.62±0.14)L、( 194±23)m、(56.2±3.8) mmHg、(55.6±3.0) mmHg、(3.2±0.6)分、(10.6±2.8)分、(10.2±2.4)分、( 36.6±2.4)mm Hg]比较差异均有统计学意义(P值分别为0.031、0.018、0.025、0.026、0.001、0.013、0.002、0.014);HNIPPV组FEV1、FVC改善均优于对照组,但差异均无统计学意义(均P>0.05).对照组在治疗过程中有2例发生急性加重住院,住院率高于HNIPPV组,但差异无统计学意义(P>0.05).HNIPPV组患者机械通气耐受性、依从性较好,无肺气压伤.结论 HNPPV联合噻托溴铵及多索茶碱片治疗伴高碳酸血症的稳定期重度COPD安全有效.
Abstract:
Objective To evaluate the efficacy and safety of home noninvasive positive pressure ventilation (HNIPPV) in hypercapnic patients with stable severe chronic obstructive pulmonary disease (COPD).Methods Forty four patients (30 males and 14 females,mean age 68.5 years ( range:60 -80) ) were recruited from a total of 106 patients with arterial PaCO2 ≥ 55 mm Hg in Second Hospital Affiliated to Harbin Medical University from January 2009 to December 2010. Their clinical data were collected and analyzed. The patients in the HNIPPV group ( n =20 ) accepted tiotropium bromide,doxofylline tablets and HNIPPV treatment while those in the control group ( n =24) tiotropium bromide,doxofylline tablets and a low-flow inhalation of oxygen.The entire observation period was 6 months.The parameters before and after 6-month follow-up were compared,including lung function test,6-rain walking distance (6MWD),arterial blood gases (PaO2 and PaCO2 ),dyspnea grade,scores of emotional disorders and mean pulmonary artery pressure (mPAP).Results No significant difference existed in the baseline data between the HNIPPV and control groups.The forced expiratory volume in one second ( FEV1 ),forced vital capacity ( FVC),inspiratory capacity ( IC),6MWD,PaO2,PaCO2,dyspnea grade,hospitalization rate,anxiety scores,depression scores and mPAP showed no significant difference between the HNIPPV and control groups before treatment. However,at Month 6,the differences of IC,6MWD,PaO2,PaCO2,dyspnea grade,anxiety scores,depression scores and mPAP in HNIPPV group ( (1.80 ±0.14) L,(266 ±24) m,(62.6 ±4.6) mm Hg,(46.8 ±2.2) mm Hg,(2.2 ±0.5),(6.5 ±2.4),(6.0 ±1.6),(33.8 ±2.4) mm Hg) were statistically significant compared with the control group (( 1.62 ± 0.14) L,(194±23) m,(56.2±3.8) mmHg,(55.6±3.0) mmHg,(3.2±0.6),(10.6±2.8),( 10.2±2.4),(36.6 ±2.4) mmHg) (P values:0.031,0.018,0.025,0.026,0.001,0.013,0.002,0.014respectively).FEV1 and FVC in the HNIPPV group improved slightly but with no statistically significant difference (all P > 0.05 ). Two patients in the control group were taken to hospital because of acute exacerbation.And hospitalization rates increased in the control group. But no statistically significant difference existed between the HNIPPV and control groups ( P > 0.05 ).The tolerance and compliance of HNIPPV in the HNIPPV group were better and the patients in the HNIPPV group had no pulmonary barotraumas.Conclusion HNIPPV plus tiotropium bromide and doxofylline tablets is both effective and safe in the treatment of hypercapnic patient with stable severe COPD.
Author: LU Peng WU Xiao-mei LI Zhao-guo YANG Cheng-cheng
作者单位: 150086,哈尔滨医科大学附属第二医院呼吸内科
刊 名 中华医学杂志 ISTICPKU
年,卷(期): 2012, 92(6)
分类号: R4
机标分类号: R54 R56
在线出版日期: 2012年4月20日